OtherMetabolism, Transport, and Pharmacogenomics
Marked Strain Differences in the Pharmacokinetics of a VLA-4 Antagonist, 4-[1-[3-Chloro-4-[N'-(2-methylphenyl)ureido]phenylacetyl]-(4S)-fluoro-(2S)-pyrrolidine-2-yl]methoxybenzoic acid, D01-4582, in Sprague-Dawley Rats are Associated with Albumin Genetic Polymorphism
Takashi Ito, Masayuki Takahashi, Kenichi Sudo and Yuichi Sugiyama
Journal of Pharmacology and Experimental Therapeutics October 12, 2006, DOI: https://doi.org/10.1124/jpet.106.111948